0001144204-15-040067.txt : 20150630 0001144204-15-040067.hdr.sgml : 20150630 20150630170520 ACCESSION NUMBER: 0001144204-15-040067 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150630 DATE AS OF CHANGE: 20150630 EFFECTIVENESS DATE: 20150630 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gladius Pharmaceuticals Corp CENTRAL INDEX KEY: 0001646819 IRS NUMBER: 432119667 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-242835 FILM NUMBER: 15962019 BUSINESS ADDRESS: STREET 1: 2711 CENTERVILLE ROAD, SUITE 400 STREET 2: COUNTY NEWCASTLE CITY: WILMINGTON STATE: DE ZIP: 19808 BUSINESS PHONE: 514-213-4456 MAIL ADDRESS: STREET 1: 2711 CENTERVILLE ROAD, SUITE 400 STREET 2: COUNTY NEWCASTLE CITY: WILMINGTON STATE: DE ZIP: 19808 D 1 primary_doc.xml X0707 D LIVE 0001646819 Gladius Pharmaceuticals Corp 2711 CENTERVILLE RD., SUITE 400 WILMINGTON DE DELAWARE 19808 514-213-4456 DELAWARE None None Corporation true 2015 Michael Atkin 2711 Centerville Rd., Suite 400 Wilmington DE DELAWARE 19808 Executive Officer Director Pharmaceuticals No Revenues 06b false 2015-06-22 false true true Acquisition of assets owned by Sopharma, Inc., including all technology, all intellectual property rights, technical information and other company know-how materials. 0 727840 727840 0 false 2 0 0 0 false Gladius Pharmaceuticals Corp /s/ Michael Atkin Michael Atkin President & Secretary 2015-06-30